Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis

Conclusions: These results suggest that GMF change is more meaningful than WMF as a marker of tissue loss and may be useful to augment whole brain atrophy measurements in MS clinical trials.

http://msj.sagepub.com/cgi/content/abstract/22/5/668?rss=1

Source: Multiple Sclerosis - March 23, 2016 Category: Neurology Authors: Fisher, E., Nakamura, K., Lee, J.-C., You, X., Sperling, B., Rudick, R. Tags: Original Research Papers Source Type: research